ALX Oncology Holdings (ALXO)
(Delayed Data from NSDQ)
$1.09 USD
+0.04 (3.81%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $1.17 +0.08 (7.34%) 5:20 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
ALXO 1.09 +0.04(3.81%)
Will ALXO be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ALXO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALXO
ALX Oncology Holdings (ALXO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year?
ALXO: What are Zacks experts saying now?
Zacks Private Portfolio Services
ALX Oncology Holdings (ALXO) Loses -27.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Other News for ALXO
20 Day Moving Average Resistance appears for ALXO after 2.78% move
12 Health Care Stocks Moving In Thursday's After-Market Session
Is ALXO positioned for a breakout? Boomer Buy Setup shows up after gaining 2.86%
Is ALXO building bearish momentum? 20 Day Moving Average Resistance shows up after declining 0.94%
ALXO forms Slingshot Bullish on September 12